OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Average Rating of "Moderate Buy" from Analysts

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) has received an average rating of "Moderate Buy" from the six analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $35.83.

KIDS has been the topic of several analyst reports. Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating on the stock in a research report on Wednesday, March 5th. Wall Street Zen lowered shares of OrthoPediatrics from a "hold" rating to a "sell" rating in a research report on Friday, June 6th. Piper Sandler reduced their price target on shares of OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a research report on Thursday, May 8th. Truist Financial reduced their price objective on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. Finally, Lake Street Capital assumed coverage on OrthoPediatrics in a research note on Monday, April 7th. They set a "buy" rating and a $37.00 price target on the stock.

Institutional Investors Weigh In On OrthoPediatrics

Large investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC boosted its holdings in OrthoPediatrics by 4,618.2% in the first quarter. GAMMA Investing LLC now owns 10,616 shares of the company's stock worth $261,000 after acquiring an additional 10,391 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of OrthoPediatrics by 29.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company's stock valued at $15,576,000 after purchasing an additional 152,681 shares in the last quarter. SG Americas Securities LLC lifted its holdings in shares of OrthoPediatrics by 175.0% in the first quarter. SG Americas Securities LLC now owns 20,039 shares of the company's stock valued at $494,000 after purchasing an additional 12,753 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of OrthoPediatrics by 204.8% in the fourth quarter. JPMorgan Chase & Co. now owns 42,817 shares of the company's stock valued at $992,000 after purchasing an additional 28,768 shares in the last quarter. Finally, HighTower Advisors LLC bought a new position in shares of OrthoPediatrics in the fourth quarter valued at approximately $268,000. Institutional investors and hedge funds own 69.05% of the company's stock.

OrthoPediatrics Price Performance

Shares of KIDS stock opened at $21.77 on Friday. OrthoPediatrics has a 12-month low of $19.52 and a 12-month high of $35.99. The firm has a market capitalization of $528.79 million, a price-to-earnings ratio of -12.44 and a beta of 1.08. The company has a quick ratio of 2.99, a current ratio of 6.19 and a debt-to-equity ratio of 0.21. The firm has a fifty day moving average of $21.38 and a 200-day moving average of $23.08.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.13). OrthoPediatrics had a negative return on equity of 7.03% and a negative net margin of 19.15%. The business had revenue of $52.41 million for the quarter, compared to the consensus estimate of $51.68 million. On average, equities research analysts forecast that OrthoPediatrics will post -0.93 earnings per share for the current year.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.